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Abstract In£ammatory responses of human peripheral blood
monocytes to the Gram-negative endotoxin lipopolysaccharide
(LPS) are enhanced by structurally diverse substances, such as
anionic polysaccharides or cationic polypeptides. Only a few
substances are known to e¡ectively blunt LPS-induced mono-
cyte activation. We now show that synthetic poly-L-histidine
(Hn) binds to LPS and abrogates the release of the proin£am-
matory cytokine interleukin-8 (IL-8) in LPS-stimulated human
whole blood. LPS-induced stimulation of monocytes was strictly
pH-dependent with only minor amounts of IL-8 secreted in
acidic blood. Maximum levels of IL-8 secretion occurred at a
strongly basic pH. Hn inhibition of the release of IL-8 from
LPS-stimulated monocytes was observed under acidic, neutral
and physiological conditions. With increasing alkalosis, the ef-
fectiveness of Hn was gradually lost, suggesting that protonated,
but not deprotonated, Hn was e¡ective in inhibiting LPS-in-
duced monocyte responses. Histidine-rich protein 2 from the
malaria parasite, Plasmodium falciparum, inhibited the ability
of LPS to evoke an in£ammatory response in CD14-transfected
THP-1 cells. Further, a short synthetic peptide derived from
human histidine- and proline-rich glycoprotein also exhibited
LPS-inhibitory e¡ects in CD14 transfectants. Taken together,
these observations demonstrate the capacity of histidine-rich
peptides, irrespective of their origin, to neutralize LPS-induced
proin£ammatory host responses.
2 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Endotoxins such as bacterial lipopolysaccharides (LPS) ac-
tivate monocytes and macrophages through a number of LPS
recognition molecules, such as CD14 [1] and CD11b/CD18
[2,3], or through class A macrophage scavenger receptors
[4]. CD14, for example, is a glycosylphosphatidylinositol
(GPI)-anchored protein that responds to subnanomolar con-
centrations of LPS [1]. The unique sensitivity of CD14 for
LPS depends on LPS-binding protein (LBP), a liver-derived
high-a⁄nity LPS-binding protein present in human plasma
[5]. Plasma-borne LPS is rapidly captured by LBP [5], and
the resulting LPS^LBP complex is recognized by cell-associ-
ated CD14 [1]. Subsequent association of CD14 with Toll-like
receptor 4 [6] triggers a signaling pathway that releases a
number of proin£ammatory mediators, notably tumor ne-
crosis factor-K (TNFK) [7], a cytokine that plays a pivotal
role in the development of septic shock syndrome [8].
Bactericidal permeability-increasing protein (BPI) shares ex-
tensive amino acid sequence identity with LBP [5], and, like
LBP, binds LPS with high a⁄nity [5]. Interestingly, BPI in-
hibits LPS-induced cell activation [9]. The opposing e¡ects of
the two closely related LPS-binding proteins, LBP and BPI,
on LPS activation demonstrate the complexity with which
LPS responses are modi¢ed.
Previously, we have shown that CAP37 and other arginine-
rich cationic polypeptides enhance LPS-induced monocyte ac-
tivation in human peripheral blood [10]. In addition, we have
demonstrated that the enhancement of LPS responses is not a
unique property of LPS-binding proteins. Heparin and fucoi-
dan, two polysulfated carbohydrates, for example, increase
LPS-induced TNFK production in isolated human monocytes
[11,12].
There are relatively few naturally occurring LPS-neutraliz-
ing substances, and these mostly consist of cationic polypep-
tides, such as BPI [9] or CAP18 [13]. In this paper, we show
that at physiological pH, poly-L-histidines (Hn) neutralize the
e¡ects of LPS, as measured by the suppression of LPS-in-
duced interleukin-8 (IL-8) production in human whole blood.
LPS inhibition was also observed with histidine-rich protein 2
(HRP2), derived from the malaria parasite, Plasmodium falci-
parum, and with a synthetic 25-mer peptide, identical to a
histidine-rich consensus sequence of human histidine- and
proline-rich glycoprotein (HPRG). The data presented here
provide evidence that histidine-rich peptides are novel LPS
antagonists and set the stage for the exploration of their ther-
apeutic potential.
2. Materials and methods
2.1. Reagents
RPMI 1640 medium, phosphate-bu¡ered saline (PBS), citric acid,
Escherichia coli 0111:B4 LPS, £uorescein isothiocyanate (FITC)-con-
jugated LPS (LPS-FITC), Hn, poly-L-arginine (Rn), high-capacity
nickel chelate a⁄nity matrix (Ni-CAM1 HC Resin), and trypan
blue were purchased from Sigma (St. Louis, MO, USA). Sodium car-
bonate and imidazole were obtained from Merck (Darmstadt, Ger-
many), and recombinant IL-8 was acquired from PharMingen (Becton
Dickinson, Franklin Lakes, NJ, USA). Finally, HRP2 was kindly
provided by Hans-Peter Beck (Tropical Institute, Basel, Switzerland).
2.2. Whole blood assay
Human whole blood from healthy donors was collected in ethyl-
enediaminetetraacetic acid (EDTA) and acid citrate dextrose vacu-
tainers (Becton Dickinson). Citrated whole blood was immediately
diluted with an equal volume of RPMI 1640 medium. Where indi-
cated, 0.3 M citric acid or 0.3 M Na2CO3 was added for pH adjust-
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ment. Subsequently, LPS (10 ng/ml), Hn (10 Wg/ml), Rn (10 Wg/ml), or
imidazole (1 mM) were added where indicated. Samples were then
incubated for 4 h at 37‡C, and supernatants were stored at 320‡C.
EDTA blood was used to determine the number of peripheral blood
monocytes. Brie£y, cells were stained for endogenous peroxidase and
analyzed by £ow cytometry on an ADVIA120 instrument (Bayer Di-
agnostics, Munich, Germany).
2.3. In vitro binding assay
Fifty microliters of packed nickel chelate a⁄nity matrix were
washed in PBS and incubated overnight at room temperature in
1 ml of PBS containing 10 mg of Hn. The matrix was washed in
PBS to remove unbound Hn and 100 Wl of saline was added, in the
presence or absence of 10 Wg LPS-FITC, with or without 10 mg Hn.
After an additional incubation period of 2 h at room temperature, the
matrix was washed in PBS, and bound £uorescence was measured at
485 nm using a FLUOstar SLT microplate £uorescence reader
(TECAN Group, Mannedorf, Switzerland).
2.4. Enzyme-linked immunosorbent assay
Supernatants were thawed and the levels of IL-8 or TNFK were
determined by sandwich enzyme-linked immunosorbent assay (ELI-
SA). MaxiSorp1 Surface Nunc-Immuno1 Plates (Life Technologies
Invitrogen, Basel, Switzerland) were used to maximize sensitivity.
Plates were coated overnight at 4‡C in 0.1 M carbonate bu¡er (pH
9.5) using pretitrated antibodies (OptEIA1) from PharMingen (Bec-
ton Dickinson). Absorbance at 405 nm was measured using a Titertek
Multiskan device from Flow Laboratories (ICN Pharmaceuticals,
Costa Mesa, CA, USA).
2.5. Cell culture
Stably transfected THP-1 cell lines expressing GPI-anchored human
CD14 [14] were a gift from Jerome Pugin (University Hospital, Gen-
eva, Switzerland) and were cultured as described [15]. CD14 trans-
fectants were incubated at 37‡C for 4 h in serum-free AIM-V0 me-
dium (Invitrogen, Basel, Switzerland) with or without LPS (10 ng/ml),
in the presence or absence of HRP2 (1037 M). CD14 transfectants
were resuspended in serum-free AIM-V0 medium, containing LPS
(10 ng/ml) and increasing concentrations (1039 M, 1037 M, 1036 M,
1035 M, 1034 M) of human HPRG-derived peptide (residues 383^
407). After 4 h at 37‡C, supernatants were collected and stored at
320‡C.
2.6. Peptide synthesis and puri¢cation
A 25-mer peptide with the sequence þH3N-GHHPHGHHP-
HGHHPHGHHPHGHHPH-COO3, corresponding to residues 383^
407 of human HPRG, was synthesized on an Applied Biosystems
433A peptide synthesizer as described [16]. The peptide was then
puri¢ed by high-performance liquid chromatography (AKTA puri¢er,
Pharmacia Biotech Amersham Biosciences, Otel¢ngen, Switzerland)
on a WRPC C2/C18 column (4.6 mm in diameter and 100 mm in
length; Pharmacia Biotech), using a linear solvent gradient (¢rst sol-
vent, 0.1% tri£uoroacetic acid (TFA); second solvent, 0.08% TFA in
84% acetonitrile). The product was lyophilized and resolved in 1 M
acetic acid. Its purity was demonstrated by acid hydrolysis and amino
acid analysis using electrospray mass spectrometry on an API III
triple-quadrupole biomolecular mass analyzer (SCIEX Applied Bio-
systems, Foster City, CA, USA).
2.7. Statistical analysis
Data were analyzed by analysis of variance and Fishers’ probable
least-squares di¡erence test. P values smaller than 0.05 were consid-
ered to be signi¢cant.
3. Results
3.1. Synthetic Hn polymers bind to LPS
We ¢rst examined whether synthetic Hn polymers bind spe-
ci¢cally to LPS. Hn was immobilized on a nickel chelate af-
¢nity matrix, and aliquots of Hn-saturated matrix samples
were equilibrated with or without LPS-FITC. As shown in
Fig. 1, the binding of LPS-FITC to matrix-immobilized Hn
was speci¢c, as demonstrated by the complete abrogation of
the binding of LPS-FITC to immobilized Hn after the addi-
tion of excess free Hn together with LPS-FITC.
3.2. Hn suppresses LPS-induced production of IL-8 in human
whole blood
We next tested the e¡ect of LPS on the production of two
proin£ammatory cytokines, IL-8 and TNFK, in citrated and
RPMI-diluted human whole blood. In a preliminary experi-
ment, we found that in diluted blood samples that were pro-
cessed immediately after the addition of high concentrations
of LPS (1 Wg/ml), IL-8 and TNFK levels were undetectable
(n=5). However, in diluted whole blood samples that were
incubated at 37‡C for 4 h after the addition of LPS (1 Wg/
ml), levels of IL-8 and TNFK were 272S 159 and 1403S 423
pg/105 monocytes, respectively (n=5). Interestingly, incubat-
ing diluted blood samples with low (10 ng/ml) or high (1 Wg/
ml) concentrations of LPS for 4 h at 37‡C resulted in the
production of similar amounts of IL-8 (10 ng/ml LPS:
210S 156 pg IL-8/105 monocytes (n=5); 1 Wg/ml LPS:
254S 200 pg IL-8/105 monocytes (n=5); Ps 0.05). This ob-
servation, together with the fact that septic patients typically
exhibit low plasma levels of LPS, identi¢es IL-8 as a suitable
marker to study the anti-in£ammatory e¡ects of LPS-neutral-
izing substances.
Next, we examined the e¡ect of Hn on IL-8 production in
LPS-stimulated human whole blood (Fig. 2A). The addition
of LPS to human whole blood (10 ng/ml) resulted in signi¢-
cant accumulation of extracellular IL-8, whereas treatment
with Hn alone (10 Wg/ml) did not induce IL-8 secretion. How-
ever, when Hn (10 Wg/ml) was added together with LPS (10 ng/
ml), IL-8 production was suppressed to a level that was barely
detectable. The pH of citrated blood samples varied only
slightly, ranging from pH 7.0 to pH 7.1.
3.3. Hn-mediated suppression of LPS-induced IL-8 production
in whole blood is reversed by imidazole
Having shown that Hn e¡ectively suppresses LPS-induced
in£ammatory responses (Fig. 2A), we next examined the e¡ect
of imidazole on IL-8 production in LPS- and Hn-treated hu-
man whole blood (Fig. 2B). In this experiment, it was again
Fig. 1. Binding of LPS-FITC to Hn. Aliquots of nickel chelate af-
¢nity matrix (50 Wl), saturated with Hn, were incubated with either
saline, saline containing LPS-FITC (10 Wg) or saline containing a
mixture of LPS-FITC (10 Wg) and excess free Hn (10 mg). Matrix
samples were washed and associated £uorescence measured. Data
are expressed as mean valueS 1 S.D., expressed as percentage of
maximum detectable £uorescence (n=3).
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shown that Hn (10 Wg/ml) completely suppressed LPS-induced
IL-8 production. Imidazole (1 mM) alone did not a¡ect IL-8
production, and it did not signi¢cantly a¡ect LPS-evoked
IL-8 production in the absence of Hn (10 Wg/ml). However,
if imidazole (1 mM) was added together with Hn (10 Wg/ml),
the suppressive e¡ect of Hn on LPS-induced IL-8 production
was abolished. There was even a moderate enhancement of
LPS-induced IL-8 production (compared with the level of
IL-8 induced by LPS alone). The underlying mechanism for
this enhancement is currently unknown. Taken together, these
results suggest that the neutralization of LPS-induced in-
creases in IL-8 production by Hn is mediated by the imidazole
ring structures that are present within Hn.
3.4. Hn-mediated suppression of LPS-induced IL-8 production
in whole blood is reversed by synthetic L-arginine polymers
The observed suppression of LPS-induced IL-8 production
by Hn could simply re£ect an Hn-associated cytotoxicity. To
address this possibility, we used Rn to examine if monocytes
were capable of producing IL-8 in response to the addition of
Hn. First, we stimulated human whole blood with LPS (10 ng/
ml), thereby inducing IL-8 secretion (Fig. 2C). As observed
previously, IL-8 could not be detected in blood samples that
were incubated with Hn (10 Wg/ml) in the presence or absence
of LPS (10 ng/ml). However, in the presence of both Hn
(10 Wg/ml) and Rn (10 Wg/ml), LPS re-induced IL-8 to levels
observed in samples treated with Rn and LPS alone (Figs. 2C
and 3C, pH 7.0). In addition to demonstrating that the e¡ects
of Rn on enhancing LPS [10] are dominant over the e¡ects of
Hn on suppressing LPS, these data show that Hn (10 Wg/ml) is
not toxic to blood monocytes.
3.5. LPS-induced production of IL-8 is pH-dependent:
protonated but not deprotonated Hn neutralizes
LPS responses
The pKa value of L-histidine is nearly identical to the pH of
citrated whole blood. As a result, charged forms of L-histidine
side chains predominate in acidic blood. Blood alkalosis, on
the other hand, creates predominantly uncharged forms of
L-histidine. In order to delineate the possible e¡ects of pH
on Hn-mediated LPS suppression, we ¢rst examined whether
LPS responses, per se, depend on pH. Interestingly, LPS-in-
duced IL-8 production showed a notable pH dependence. At
an acidic pH (pH 6.6), levels of secreted IL-8 were barely
detectable (Fig. 3A). However, substantial LPS-induced IL-8
release was noted at strongly basic pH levels (Fig. 3A, pH 7.8,
pH 8.2). Even in the absence of exogenous LPS, small but
reproducible levels of IL-8 release were detected at pH 8.2
(Fig. 3A^C), presumably due to LPS contaminants from the
laboratory.
In the presence of Hn (10 Wg/ml), LPS-induced IL-8 pro-
duction was completely abolished at acidic (pH 6.6), neutral
(pH 7.0) and physiological (pH 7.4) pH (Fig. 3B). However,
the observed Hn-mediated suppression of LPS responses was
6
Fig. 2. A: E¡ect of Hn on LPS-induced IL-8 production in human
whole blood. Citrated whole blood was obtained from four healthy
subjects and diluted 1:1 with RPMI 1640 medium. Aliquots of di-
luted whole blood (pH 7.0^7.1) were treated with or without LPS
(10 ng/ml) in the presence or absence of Hn (10 Wg/ml). Samples
were incubated at 37‡C for 4 h, and supernatants were probed for
secreted IL-8 by ELISA. Monocyte counts were determined in
EDTA blood using automated £ow cytometry. Depicted values rep-
resent pg amounts of IL-8, released by 105 monocytes. B: E¡ect of
imidazole on Hn- and LPS-treated human whole blood. The same
experiment as described in A was carried out except that imidazole
(1 mg/ml) was added as indicated. C: E¡ect of Rn on Hn- and
LPS-treated human whole blood. The same experiment as described
in A was carried out except that Rn (10 Wg/ml) was added as indi-
cated. The addition of LPS alone is indicated by white bars. Data
are expressed as mean valueS 1 S.D. (n=4).
FEBS 27650 24-9-03
H. Bosshart, M. Heinzelmann/FEBS Letters 553 (2003) 135^140 137
gradually lost at higher pH levels (Fig. 3B, pH 7.8, pH 8.2,
pH 8.6), indicating that cationic, but not neutral forms of Hn
were able to neutralize LPS.
Rn, a potent ampli¢er of LPS responses at neutral and
physiological pH [10], enhanced LPS-induced IL-8 production
at both acidic and basic pH levels (Fig. 3C). The enhancement
was more pronounced at acidic (pH 6.6), neutral (pH 7.0),
and physiological (pH 7.4) pH levels (Fig. 3C) and was some-
what less prominent at higher pH levels (Fig. 3C, pH 7.8, pH
8.2, pH 8.6). These observations demonstrate that the dimin-
ished capacity of peripheral blood monocytes to mount in-
£ammatory LPS responses in an acidic environment (Fig.
3A, pH 6.6) is not due to cytotoxicity (Fig. 3C, pH 6.6).
Having ruled out the possibility of toxic e¡ects of Hn or
acidic pH, we next asked whether variations in pH levels or
the presence of poly-L-amino acids (Hn or Rn) could a¡ect
IL-8 measurement. To do this, we added recombinant IL-8 (1
ng/ml), Hn (10 Wg/ml), and Rn (10 Wg/ml) to fetal calf serum
diluted 1:1 with RPMI and titrated the samples to the pH
values indicated in Fig. 3. Determination of IL-8 levels by
ELISA showed that IL-8 detection (the ability to measure
IL-8) decreased to 97% at pH 6.6 and 7.8, 95% at pH 8.2,
and 90% at pH 8.6, as compared with values measured at
neutral or physiological pH. The addition of Hn (10 Wg/ml)
a¡ected IL-8 detection only slightly (maximum deviation 3%).
The addition of Rn decreased IL-8 detection by 4% at acidic,
neutral and physiological pH, and by 10% at basic pH.
3.6. Synthetic L-histidine polymers suppress LPS-induced
production of IL-8 in CD14-transfected THP-1 cells
In order to test for the ability of naturally occurring histi-
dine-rich proteins or derived peptide sequences to inhibit LPS
responses, we established a cell culture system in which LPS
activation could be evaluated under serum-free conditions, i.e.
in the absence of serum-derived histidine-rich proteins. For
this purpose, we used THP-1 cells stably transfected with ei-
ther the rsv vector alone (rsv) or with an rsv vector containing
the sequence for GPI-anchored human CD14 (rsv-CD14) [14].
LPS-induced activation of THP-1 cells was strictly dependent
on the presence of the transfected CD14 vector (Fig. 4A). As
in human whole blood (Fig. 2A), Hn (10 Wg/ml) neutralized
proin£ammatory LPS (10 ng/ml) e¡ects in CD14 transfectants
after a 4 h incubation (Fig. 4A).
To examine whether long-term exposure to Hn was toxic to
THP-1 cells, we incubated rsv- and rsv-CD14-transfected
THP-1 cells in the presence or absence of Hn (10 Wg/ml) for
24 h at 37‡C and determined cytotoxicity by counting the
number of cells that excluded the cell-impermeable dye, try-
pan blue. In rsv-transfected cells, cell viability in the presence
of Hn was 81S 6% (n=5) and the viability in the absence of
Hn was 78S 10% (n=5), where the data are expressed as the
number of cells excluding the dye (Ps 0.05). In rsv-CD14-
transfected cells, cell viability was 89S 8% (n=5) in the pres-
ence of Hn and 89S 10% (n=5) in the absence of Hn
(Ps 0.05).
Next, rsv-CD14-transfected THP-1 cells were preincubated
with both Hn and LPS, and the ability of the cells to produce
IL-8 was measured after Hn washout. The cells were preincu-
bated in the presence or absence of Hn (10 Wg/ml) and LPS
(10 ng/ml) at 37‡C for 2 h. After preincubation, cells were
washed and fresh medium containing LPS (10 ng/ml) was
added. At the end of an additional 2 h incubation period,
the cells were centrifuged at 600Ug for 5 min and IL-8 con-
centrations were determined in the supernatants. Cells prein-
cubated with saline released 786S26 pg IL-8/106 cells, where-
as cells preincubated with LPS and Hn released 652S 41 pg
Fig. 3. E¡ects of varying pH on LPS-induced IL-8 production in
human whole blood. Citrated whole blood was obtained from four
healthy donors and diluted 1:1 with RPMI 1640 medium. Diluted
whole blood (pH 7.0^7.1) was divided into aliquots and the pH was
adjusted as indicated, using 0.3 M citric acid and 0.3 M Na2CO3.
After the addition of saline (open symbols) or 10 ng/ml LPS (closed
symbols), samples were divided further and aliquots were treated
with (A) saline, (B) 10 Wg/ml Hn or (C) 10 Wg/ml Rn. Samples were
incubated at 37‡C for 4 h, and the supernatants were analyzed for
secreted IL-8 by ELISA. Monocyte counts were determined by au-
tomated £ow cytometry. Data are expressed as mean valueS 1 S.D.
(n=4). Mean values obtained with LPS treatment alone (A) are in-
dicated by dashed lines in B and C.
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IL-8/106 cells (n=4 in each group, P6 0.05). Because a 24 h
incubation with Hn did not a¡ect the viability of transfected
THP-1 cells, and because preincubation with Hn and LPS did
not abolish LPS-induced IL-8 production 2 h after washout,
Hn-mediated cytotoxicity cannot account for the complete
lack of IL-8 release in LPS-stimulated CD14þ cells (Fig. 4A).
3.7. HRP2, derived from the malaria parasite, P. falciparum,
suppresses LPS-induced IL-8 production in CD14-
transfected THP-1 cells
CD14-transfected THP-1 cells were resuspended in serum-
free medium. A naturally occurring histidine-rich protein,
HRP2, which is derived from the malaria parasite, P. falcipa-
rum, was added in the presence or absence of LPS (10 ng/ml).
HPR2 (1037 M) decreased IL-8 production by approximately
80% (Fig. 4B).
3.8. A histidine-rich synthetic peptide, derived from human
HPRG, inhibits LPS-induced IL-8 production in
CD14-transfected THP-1 cells
A 25-mer peptide, corresponding to residues 383^407 of
human HPRG [17], was synthesized and tested for its e¡ects
on LPS responses. HPRG383407 dose-dependently inhibited
the release of IL-8 in LPS-stimulated CD14-transfected
THP-1 cells (Fig. 4C). Taken together, our observations dem-
onstrate that histidine-rich peptides, irrespective of their ori-
gin, can neutralize LPS-induced proin£ammatory host re-
sponses.
4. Discussion
In the present study, we showed that Hn polypeptide chains
speci¢cally bind to LPS-FITC. Moreover, Hn chains neutral-
ize the proin£ammatory e¡ects of LPS in human whole blood.
The use of whole blood preparations requires some form of
anticoagulation. The most commonly used anticoagulants are
heparin, EDTA, and citrate. Because we were investigating
the possible e¡ects of Hn on LPS-induced in£ammatory re-
sponses in whole blood, heparin was precluded as an antico-
agulant because it strongly enhances LPS responses [11].
EDTA, on the other hand, suppresses LPS-induced cytokine
production [18].
Histidine is unique among amino acids in that it exists in a
partially protonated and partially deprotonated form at phys-
iological pH. Changes in pH are therefore likely to in£uence
the biological e¡ects exerted by histidines. Thus, we per-
formed a systematic analysis of the e¡ects of pH on histidine
neutralization of the proin£ammatory e¡ect of LPS. We were
surprised to ¢nd that the LPS-induced release of IL-8 in cit-
rated human whole blood showed a remarkable pH depen-
dence. In acidic blood, the e¡ects of LPS progressively faded.
Under conditions of alkalosis, however, LPS-induced IL-8
production increased dramatically. The cause for this pH de-
pendence is currently not known and might be di⁄cult to
6
Fig. 4. E¡ects of HRP2 and HPRG383407 on LPS-induced IL-8
production in CD14-transfected THP-1 cells. A: THP-1 cells were
stably transfected with either the empty rsv vector (rsv) or with the
rsv vector including the inserted sequence of GPI-anchored human
CD14 (rsv-CD14). Cells were incubated in serum-free AIM-V0 me-
dium (pH 7.4) for 4 h at 37‡C, with or without LPS (10 ng/ml) and
in the presence or absence of Hn (10 Wg/ml). Supernatants were col-
lected, and secreted IL-8 was determined by ELISA. B: CD14-trans-
fected THP-1 cells were treated with or without LPS (10 ng/ml) in
the presence or absence of HRP2 (1037 M), and samples were pro-
cessed as described in A. C: CD14-transfected THP-1 cells were
treated with LPS (10 ng/ml) and increasing concentrations (1039 M,
1037 M, 1036 M, 1035 M, 1034 M) of the HPRG383407 peptide.
Samples were processed as described in A. Data are expressed as
mean valueS 1 S.D. (n=3).
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elucidate, because in diluted whole blood, any number of
plasma constituents could contribute to this e¡ect.
Hn speci¢cally bound to LPS-FITC, and Hn-mediated LPS
inhibition was associated with positively charged, but not un-
charged, forms of L-histidine side chains. Taken together,
these ¢ndings suggest that the observed LPS-neutralizing ef-
fects of Hn were likely to result from electrostatic interactions
between histidines and the negatively charged phosphate
groups in the lipid A portion of LPS. Phosphate groups are
of critical importance for LPS to e¡ectively stimulate target
cells. For example, dephosphorylated LPS or LPS from Rho-
dospirillum fulvum, in which the two phosphate residues are
replaced by galacturonic acid and heptose, respectively, only
induced production of the proin£ammatory cytokine IL-6 in
human whole blood at high concentrations (above 10 ng/ml)
[19].
One of the most histidine-rich proteins identi¢ed to date is
derived from the bird malaria parasite, Plasmodium lophurae
[20]. The histidine-rich protein of P. lophurae, which has been
implicated in erythrocyte invasion [21], contains 74% histidine
[22]. The histidines are arranged in stretches of up to nine
consecutive residues, sometimes separated by only one or
two non-histidine residues. This histidine-rich protein from
P. lophurae is essentially a naturally occurring variant of the
synthetic Hn used in this study. The human malaria parasite,
P. falciparum, also produces histidine-rich proteins, such as
HRP2, which contains 31% histidine [23]. We found that
HRP2 e¡ectively neutralizes LPS. Taken together with the
fact that charged poly-L-amino acids, such as Hn, are random
coils without de¢ned secondary structural features, this ¢nd-
ing strongly suggests that a high histidine content alone may
be su⁄cient to blunt LPS responses.
HPRG is an abundant human plasma protein that contains
13% histidine [24]. We tested whether the HPRG-derived con-
sensus sequence, þH3N-(GHHPH)5-COO3, could reduce the
proin£ammatory e¡ects of LPS. Diminished LPS activation
was observed in the presence of this peptide, although a rel-
atively high peptide concentration was required for half-max-
imal inhibition.
Interestingly, HPRG (average plasma concentration 100 Wg/
ml) is also known to bind and neutralize heparin [25]. Accord-
ingly, this protein must be ¢rst titrated in order for heparin to
exert its anticoagulant e¡ects in the bloodstream [26]. Future
studies will show whether HPRG bu¡ers LPS as well as hep-
arin, and may thus play an important role in immune defense.
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